{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:04:59Z","timestamp":1790301899905,"version":"4.1.0"},"reference-count":88,"publisher":"China Science Publishing & Media Ltd.","issue":"6","funder":[{"name":"National Natural Science Foundation of China","award":["50110000180981470434 and 81270420"],"award-info":[{"award-number":["50110000180981470434 and 81270420"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2014M560647 and 2015T80875"],"award-info":[{"award-number":["2014M560647 and 2015T80875"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Province Cooperative innovation Center for Molecular Target New Drug Study"},{"name":"Hunan Provincial Education Department Document","award":["2014-405"],"award-info":[{"award-number":["2014-405"]}]},{"DOI":"10.13039\/501100005225","name":"Key Discipline in Hunan Province","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005225","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["14JJ3102"],"award-info":[{"award-number":["14JJ3102"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Provincial Science and Technology Project","award":["2015RS4040"],"award-info":[{"award-number":["2015RS4040"]}]},{"name":"Administration of Traditional Chinese Medicine of Hunan Province","award":["201578"],"award-info":[{"award-number":["201578"]}]},{"DOI":"10.13039\/501100010451","name":"Health and Family Planning Commission of Hunan Province","doi-asserted-by":"crossref","award":["B2015-48"],"award-info":[{"award-number":["B2015-48"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1093\/abbs\/gmx035","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T11:17:59Z","timestamp":1491477479000},"page":"471-478","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":37,"title":["Novel pathogenesis: regulation of apoptosis by Apelin\/APJ system"],"prefix":"10.3724","volume":"49","author":[{"given":"Jiaqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","volume":"251","author":"Tatemoto K","year":"1998","unstructured":"Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun, 1998, 251: 471-476.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejheart.2008.06.002","volume":"10","author":"Chandrasekaran B","year":"2008","unstructured":"Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail, 2008, 10: 725-732.","journal-title":"Eur J Heart Fail"},{"key":"null","doi-asserted-by":"crossref","first-page":"H1904","DOI":"10.1152\/ajpheart.00686.2009","volume":"297","author":"Charo DN","year":"2009","unstructured":"Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol, 2009, 297: H1904-H1913.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","volume":"91","author":"Szokodi I","year":"2002","unstructured":"Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res, 2002, 91: 434-440.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","volume":"99","author":"Tatemoto K","year":"2001","unstructured":"Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept, 2001, 99: 87-92.","journal-title":"Regul Pept"},{"key":"null","first-page":"337","volume":"16","author":"Esposito V","year":"2002","unstructured":"Esposito V, De Falco M, De Luca L, Acanfora F, Onori N, Loiacono L, Montesarchio V. Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia. In Vivo, 2002, 16: 337-340.","journal-title":"In Vivo"},{"key":"null","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2003.08.029","volume":"144","author":"Horiuchi Y","year":"2003","unstructured":"Horiuchi Y, Fujii T, Kamimura Y, Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. J Neuroimmunol, 2003, 144: 46-52.","journal-title":"J Neuroimmunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","volume":"1538","author":"Kawamata Y","year":"2001","unstructured":"Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta, 2001, 1538: 162-171.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-4889(99)00114-7","volume":"1452","author":"Habata Y","year":"1999","unstructured":"Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta, 1999, 1452: 25-35.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0167-4889(01)00135-5","volume":"1540","author":"Fukusumi S","year":"2001","unstructured":"Fukusumi S, Habata Y, Yoshida H, Iijima N, Kawamata Y, Hosoya M, Fujii R. Characteristics and distribution of endogenous RFamide-related peptide-1. Biochim Biophys Acta, 2001, 1540: 221-232.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","volume":"74","author":"Lee DK","year":"2000","unstructured":"Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH. Characterization of apelin, the ligand for the APJ receptor. J Neurochem, 2000, 74: 34-41.","journal-title":"J Neurochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cellsig.2004.09.018","volume":"17","author":"Masri B","year":"2005","unstructured":"Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal, 2005, 17: 415-426.","journal-title":"Cell Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/aps.2015.145","volume":"37","author":"Liu MQ","year":"2016","unstructured":"Liu MQ, Chen Z, Chen LX. Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases. Acta Pharmacol Sin, 2016, 37: 425-443.","journal-title":"Acta Pharmacol Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2013.09.001","volume":"428","author":"Yu XH","year":"2014","unstructured":"Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP. Apelin and its receptor APJ in cardiovascular diseases. Clin Chim Acta, 2014, 428: 1-8.","journal-title":"Clin Chim Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"H585","DOI":"10.1152\/ajpheart.00821.2013","volume":"306","author":"Zeng H","year":"2014","unstructured":"Zeng H, He X, Hou X, Li L, Chen JX. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3. Am J Physiol Heart Circ Physiol, 2014, 306: H585-H597.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.acthis.2013.12.004","volume":"116","author":"Ustunel I","year":"2014","unstructured":"Ustunel I, Acar N, Gemici B, Ozbey O, Edizer I, Soylu H, Tepekoy F. The effects of water immersion and restraint stress on the expressions of apelin, apelin receptor (APJR) and apoptosis rate in the rat heart. Acta Histochem, 2014, 116: 675-681.","journal-title":"Acta Histochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejca.2013.11.017","volume":"50","author":"Picault FX","year":"2014","unstructured":"Picault FX, Chaves-Almagro C, Projetti F, Prats H, Masri B, Audigier Y. Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas. Eur J Cancer, 2014, 50: 663-674.","journal-title":"Eur J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diabres.2012.09.045","volume":"99","author":"Lu Q","year":"2013","unstructured":"Lu Q, Jiang YR, Qian J, Tao Y. Apelin-13 regulates proliferation, migration and survival of retinal Muller cells under hypoxia. Diabetes Res Clin Pract, 2013, 99: 158-167.","journal-title":"Diabetes Res Clin Pract"},{"key":"null","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/2045-8932.87299","volume":"1","author":"Andersen CU","year":"2011","unstructured":"Andersen CU, Hilberg O, Mellemkjaer S, Nielsen-Kudsk JE, Simonsen U. Apelin and pulmonary hypertension. Pulm Circ, 2011, 1: 334-346.","journal-title":"Pulm Circ"},{"key":"null","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/bph.13485","volume":"173","author":"Boal F","year":"2016","unstructured":"Boal F, Timotin A, Roumegoux J, Alfarano C, Calise D, Anesia R, Parini A. Apelin-13 administration protects against ischaemia\/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity. Br J Pharmacol, 2016, 173: 1850-1863.","journal-title":"Br J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00726-010-0555-x","volume":"39","author":"Cui RR","year":"2010","unstructured":"Cui RR, Mao DA, Yi L, Wang C, Zhang XX, Xie H, Wu XP. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ\/PI3-K\/Akt signaling pathways. Amino Acids, 2010, 39: 1193-1200.","journal-title":"Amino Acids"},{"key":"null","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","volume":"121","author":"Alastalo TP","year":"2011","unstructured":"Alastalo TP, Li M, Perez Vde J, Pham D, Sawada H, Wang JK, Koskenvuo M. Disruption of PPARgamma\/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest, 2011, 121: 3735-3746.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1440-1681.12563","volume":"43","author":"Lv D","year":"2016","unstructured":"Lv D, Li L, Lu Q, Li Y, Xie F, Li H, Cao J. PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13. Clin Exp Pharmacol Physiol, 2016, 43: 569-579.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"H1471","DOI":"10.1152\/ajpheart.00097.2011","volume":"301","author":"Tao J","year":"2011","unstructured":"Tao J, Zhu W, Li Y, Xin P, Li J, Liu M, Li J. Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion. Am J Physiol Heart Circ Physiol, 2011, 301: H1471-H1486.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"H605","DOI":"10.1152\/ajpheart.00366.2012","volume":"303","author":"Li L","year":"2012","unstructured":"Li L, Zeng H, Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol, 2012, 303: H605-H618.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"e71041","DOI":"10.1371\/journal.pone.0071041","volume":"8","author":"Li L","year":"2013","unstructured":"Li L, Zeng H, Hou X, He X, Chen JX. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction. PLoS One, 2013, 8:","journal-title":"PLoS One"},{"key":"null","first-page":"2360","volume":"122","author":"Zhang Z","year":"2009","unstructured":"Zhang Z, Yu B, Tao GZ. Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chin Med J, 2009, 122: 2360-2365.","journal-title":"Chin Med J"},{"key":"null","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mehy.2012.08.007","volume":"79","author":"Mottaghi S","year":"2012","unstructured":"Mottaghi S, Larijani B, Sharifi AM. Apelin 13: a novel approach to enhance efficacy of hypoxic preconditioned mesenchymal stem cells for cell therapy of diabetes. Med Hypotheses, 2012, 79: 717-718.","journal-title":"Med Hypotheses"},{"key":"null","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11064-016-1878-0","volume":"41","author":"Zou Y","year":"2016","unstructured":"Zou Y, Wang B, Fu W, Zhou S, Nie Y, Tian S. Apelin-13 protects PC12 cells from corticosterone-induced apoptosis through PI3K and ERKs activation. Neurochem Res, 2016, 41: 1635-1644.","journal-title":"Neurochem Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuint.2013.09.017","volume":"63","author":"Gu Q","year":"2013","unstructured":"Gu Q, Zhai L, Feng X, Chen J, Miao Z, Ren L, Qian X. Apelin-36, a potent peptide, protects against ischemic brain injury by activating the PI3K\/Akt pathway. Neurochem Int, 2013, 63: 535-540.","journal-title":"Neurochem Int"},{"key":"null","first-page":"186946","volume":"2015","author":"Chen L","year":"2015","unstructured":"Chen L, Tao Y, Feng J, Jiang YR. Apelin protects primary rat retinal pericytes from chemical hypoxia-induced apoptosis. J Ophthalmol, 2015, 2015:","journal-title":"J Ophthalmol"},{"key":"null","first-page":"369","volume":"9","author":"Coskun Yavuz Y","year":"2015","unstructured":"Coskun Yavuz Y, Sevinc C, Deniz MS, Yavuz S, Altunoren O, Sayarlioglu H, Dogan E. The role of Apelin 13 in progression of chronic kidney disease. Iran J Kidney Dis, 2015, 9: 369-373.","journal-title":"Iran J Kidney Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.peptides.2006.10.005","volume":"28","author":"Tang SY","year":"2007","unstructured":"Tang SY, Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Zhou HD. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K\/Akt signaling pathways. Peptides, 2007, 28: 708-718.","journal-title":"Peptides"},{"key":"null","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10495-006-0489-7","volume":"12","author":"Xie H","year":"2007","unstructured":"Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Guo LJ, Zhou HD. Apelin suppresses apoptosis of human osteoblasts. Apoptosis, 2007, 12: 247-254.","journal-title":"Apoptosis"},{"key":"null","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbadis.2015.02.013","volume":"1852","author":"Chen H","year":"2015","unstructured":"Chen H, Wan D, Wang L, Peng A, Xiao H, Petersen RB, Liu C. Apelin protects against acute renal injury by inhibiting TGF-beta1. Biochim Biophys Acta, 2015, 1852: 1278-1287.","journal-title":"Biochim Biophys Acta"},{"key":"null","first-page":"423","volume":"64","author":"Antushevich H","year":"2013","unstructured":"Antushevich H, Pawlina B, Kapica M, Krawczynska A, Herman AP, Kuwahara A, Kato I. Influence of fundectomy and intraperitoneal or intragastric administration of apelin on apoptosis, mitosis, and DNA repair enzyme OGG1,2 expression in adult rats gastrointestinal tract and pancreas. J Physiol Pharmacol, 2013, 64: 423-428.","journal-title":"J Physiol Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2014.03.037","volume":"568","author":"Yang Y","year":"2014","unstructured":"Yang Y, Zhang X, Cui H, Zhang C, Zhu C, Li L. Apelin-13 protects the brain against ischemia\/reperfusion injury through activating PI3K\/Akt and ERK1\/2 signaling pathways. Neurosci Lett, 2014, 568: 44-49.","journal-title":"Neurosci Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.scr.2011.12.004","volume":"8","author":"Zeng X","year":"2012","unstructured":"Zeng X, Yu SP, Taylor T, Ogle M, Wei L. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res, 2012, 8: 357-367.","journal-title":"Stem Cell Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","volume":"9","author":"Osaki M","year":"2004","unstructured":"Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis, 2004, 9: 667-676.","journal-title":"Apoptosis"},{"key":"null","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"Datta SR","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev, 1999, 13: 2905-2927.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"Vivanco I","year":"2002","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer, 2002, 2: 489-501.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"Song G","year":"2005","unstructured":"Song G, Ouyang G, Bao S. The activation of Akt\/PKB signaling pathway and cell survival. J Cell Mol Med, 2005, 9: 59-71.","journal-title":"J Cell Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"Zha J","year":"1996","unstructured":"Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell, 1996, 87: 619-628.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1074\/jbc.M207880200","volume":"278","author":"Nomura M","year":"2003","unstructured":"Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H, Tsujimoto Y. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem, 2003, 278: 2058-2065.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1074\/jbc.M500084200","volume":"280","author":"Xin M","year":"2005","unstructured":"Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem, 2005, 280: 10781-10789.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.1202629","volume":"73","author":"Burgering BM","year":"2003","unstructured":"Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB\/Akt is off duty. J Leukoc Biol, 2003, 73: 689-701.","journal-title":"J Leukoc Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0968-0004(02)02166-7","volume":"27","author":"Mayo LD","year":"2002","unstructured":"Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci, 2002, 27: 462-467.","journal-title":"Trends Biochem Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1529\/biophysj.105.077693","volume":"91","author":"Wee KB","year":"2006","unstructured":"Wee KB, Aguda BD. Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death. Biophys J, 2006, 91: 857-865.","journal-title":"Biophys J"},{"key":"null","first-page":"488","volume":"62","author":"Gibson EM","year":"2002","unstructured":"Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res, 2002, 62: 488-496.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.devbrainres.2004.03.012","volume":"150","author":"Zsarnovszky A","year":"2004","unstructured":"Zsarnovszky A, Belcher SM. Spatial, temporal, and cellular distribution of the activated extracellular signal regulated kinases 1 and 2 in the developing and mature rat cerebellum. Brain Res Dev Brain Res, 2004, 150: 199-209.","journal-title":"Brain Res Dev Brain Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2002.tb04607.x","volume":"973","author":"Barbero S","year":"2002","unstructured":"Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL. Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann NY Acad Sci, 2002, 973: 60-69.","journal-title":"Ann NY Acad Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"16484","DOI":"10.1074\/jbc.M010384200","volume":"276","author":"Tran SE","year":"2001","unstructured":"Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE. MAPK\/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem, 2001, 276: 16484-16490.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1097-2765(02)00519-1","volume":"9","author":"Lu Z","year":"2002","unstructured":"Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1\/2. Mol Cell, 2002, 9: 945-956.","journal-title":"Mol Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1006\/bbrc.2000.3008","volume":"273","author":"Foncea R","year":"2000","unstructured":"Foncea R, Galvez A, Perez V, Morales MP, Calixto A, Melendez J, Gonzalez-Jara F. Extracellular regulated kinase, but not protein kinase C, is an antiapoptotic signal of insulin-like growth factor-1 on cultured cardiac myocytes. Biochem Biophys Res Commun, 2000, 273: 736-744.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood.V94.3.853.415a12_853_863","volume":"94","author":"Nagata Y","year":"1999","unstructured":"Nagata Y, Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood, 1999, 94: 853-863.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1091\/mbc.10.12.4231","volume":"10","author":"Park JS","year":"1999","unstructured":"Park JS, Carter S, Reardon DB, Schmidt-Ullrich R, Dent P, Fisher PB. Roles for basal and stimulated p21(Cip-1\/WAF1\/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells. Mol Biol Cell, 1999, 10: 4231-4246.","journal-title":"Mol Biol Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1074\/jbc.M107110200","volume":"277","author":"Kitagawa D","year":"2002","unstructured":"Kitagawa D, Tanemura S, Ohata S, Shimizu N, Seo J, Nishitai G, Watanabe T. Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J Biol Chem, 2002, 277: 366-371.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1074\/jbc.M107231200","volume":"277","author":"Kim SJ","year":"2002","unstructured":"Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ. ERK-1\/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem, 2002, 277: 1332-1339.","journal-title":"J Biol Chem"},{"key":"null","first-page":"L159","volume":"277","author":"Buckley S","year":"1999","unstructured":"Buckley S, Driscoll B, Barsky L, Weinberg K, Anderson K, Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am J Physiol, 1999, 277: L159-L166.","journal-title":"Am J Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/MCB.19.8.5308","volume":"19","author":"Erhardt P","year":"1999","unstructured":"Erhardt P, Schremser EJ, Cooper GM. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK\/Erk pathway. Mol Cell Biol, 1999, 19: 5308-5315.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/bj3330291","volume":"333","author":"Wang X","year":"1998","unstructured":"Wang X, Martindale JL, Liu Y, Holbrook NJ. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J, 1998, 333: 291-300.","journal-title":"Biochem J"},{"key":"null","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1091\/mbc.11.3.1103","volume":"11","author":"Le Gall M","year":"2000","unstructured":"Le Gall M, Chambard JC, Breittmayer JP, Grall D, Pouyssegur J, Van Obberghen-Schilling E. The p42\/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell, 2000, 11: 1103-1112.","journal-title":"Mol Biol Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.cdd.4401050","volume":"9","author":"Shonai T","year":"2002","unstructured":"Shonai T, Adachi M, Sakata K, Takekawa M, Endo T, Imai K, Hareyama M. MEK\/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells. Cell Death Diff, 2002, 9: 963-971.","journal-title":"Cell Death Diff"},{"key":"null","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.4049\/jimmunol.173.5.2976","volume":"173","author":"Kang TB","year":"2004","unstructured":"Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol, 2004, 173: 2976-2984.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1471-4906(00)01814-7","volume":"22","author":"Los M","year":"2001","unstructured":"Los M, Stroh C, Janicke RU, Engels IH, Schulze-Osthoff K. Caspases: more than just killers. Trends Immunol, 2001, 22: 31-34.","journal-title":"Trends Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","volume":"117","author":"Martinon F","year":"2004","unstructured":"Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell, 2004, 117: 561-574.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12031-012-9808-3","volume":"48","author":"Khaksari M","year":"2012","unstructured":"Khaksari M, Aboutaleb N, Nasirinezhad F, Vakili A, Madjd Z. Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia. J Mol Neurosci, 2012, 48: 201-208.","journal-title":"J Mol Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.devcel.2006.04.008","volume":"10","author":"Schafer ZT","year":"2006","unstructured":"Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell, 2006, 10: 549-561.","journal-title":"Dev Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1582-4934.2008.00129.x","volume":"12","author":"Ghavami S","year":"2008","unstructured":"Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med, 2008, 12: 1005-1022.","journal-title":"J Cell Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1189\/jlb.0903435","volume":"76","author":"Ghavami S","year":"2004","unstructured":"Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, Karami-Tehrani F. Mechanism of apoptosis induced by S100A8\/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol, 2004, 76: 169-175.","journal-title":"J Leukoc Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/abbs\/gmv086","volume":"47","author":"Wu D","year":"2015","unstructured":"Wu D, Chen L. Ferroptosis: a novel cell death form will be a promising therapy target for diseases. Acta Biochim Biophys Sin (Shanghai), 2015, 47: 857-859.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-007-0154-9","volume":"13","author":"Thorburn A","year":"2008","unstructured":"Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis, 2008, 13: 1-9.","journal-title":"Apoptosis"},{"key":"null","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddl036","volume":"15","author":"Ravikumar B","year":"2006","unstructured":"Ravikumar B, Berger Z, Vacher C, O'Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet, 2006, 15: 1209-1216.","journal-title":"Hum Mol Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","volume":"25","author":"Boya P","year":"2005","unstructured":"Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol, 2005, 25: 1025-1040.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"21914","DOI":"10.1038\/srep21914","volume":"6","author":"Liang D","year":"2016","unstructured":"Liang D, Han D, Fan W, Zhang R, Qiao H, Fan M, Su T. Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy. Sci Rep, 2016, 6:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4103\/1673-5374.187049","volume":"11","author":"Bao HJ","year":"2016","unstructured":"Bao HJ, Qiu HY, Kuai JX, Song CJ, Wang SX, Wang CQ, Peng HB. Apelin-13 as a novel target for intervention in secondary injury after traumatic brain injury. Neural Regen Res, 2016, 11: 1128-1133.","journal-title":"Neural Regen Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/etm.2013.902","volume":"5","author":"Jiao H","year":"2013","unstructured":"Jiao H, Zhang Z, Ma Q, Fu W, Liu Z. Mechanism underlying the inhibitory effect of Apelin-13 on glucose deprivation-induced autophagy in rat cardiomyocytes. Exp Ther Med, 2013, 5: 797-802.","journal-title":"Exp Ther Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.peptides.2009.02.010","volume":"30","author":"Zeng XJ","year":"2009","unstructured":"Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS. Apelin protects heart against ischemia\/reperfusion injury in rat. Peptides, 2009, 30: 1144-1152.","journal-title":"Peptides"},{"key":"null","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.peptides.2015.11.002","volume":"75","author":"Yang Y","year":"2016","unstructured":"Yang Y, Zhang XJ, Li LT, Cui HY, Zhang C, Zhu CH, Miao JY. Apelin-13 protects against apoptosis by activating AMP-activated protein kinase pathway in ischemia stroke. Peptides, 2016, 75: 96-100.","journal-title":"Peptides"},{"key":"null","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4103\/1673-5374.157243","volume":"10","author":"Yan XG","year":"2015","unstructured":"Yan XG, Cheng BH, Wang X, Ding LC, Liu HQ, Chen J, Bai B. Lateral intracerebroventricular injection of Apelin-13 inhibits apoptosis after cerebral ischemia\/reperfusion injury. Neural Regen Res, 2015, 10: 766-771.","journal-title":"Neural Regen Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.yexcr.2010.02.005","volume":"316","author":"Zeng XJ","year":"2010","unstructured":"Zeng XJ, Yu SP, Zhang L, Wei L. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp Cell Res, 2010, 316: 1773-1783.","journal-title":"Exp Cell Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.peptides.2011.12.015","volume":"33","author":"Wang XL","year":"2012","unstructured":"Wang XL, Tao Y, Lu Q, Jiang YR. Apelin supports primary rat retinal Muller cells under chemical hypoxia and glucose deprivation. Peptides, 2012, 33: 298-306.","journal-title":"Peptides"},{"key":"null","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.1998.00210.x","volume":"54","author":"Star RA","year":"1998","unstructured":"Star RA. Treatment of acute renal failure. Kidney Int, 1998, 54: 1817-1831.","journal-title":"Kidney Int"},{"key":"null","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/en.2012-2034","volume":"154","author":"Wattanachanya L","year":"2013","unstructured":"Wattanachanya L, Lu WD, Kundu RK, Wang L, Abbott MJ, O'Carroll D, Quertermous T. Increased bone mass in mice lacking the adipokine apelin. Endocrinology, 2013, 154: 2069-2080.","journal-title":"Endocrinology"},{"key":"null","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5603\/FHC.2014.0006","volume":"52","author":"Antushevich H","year":"2014","unstructured":"Antushevich H, Krawczynska A, Kapica M, Herman AP, Zabielski R. Effect of apelin on mitosis, apoptosis and DNA repair enzyme OGG 1\/2 expression in intestinal cell lines IEC-6 and Caco-2. Folia Histochem Cytobiol, 2014, 52: 51-59.","journal-title":"Folia Histochem Cytobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1389450115666141128120053","volume":"16","author":"Cao J","year":"2015","unstructured":"Cao J, Li H, Chen L. Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases. Curr Drug Targets, 2015, 16: 148-155.","journal-title":"Curr Drug Targets"},{"key":"null","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","volume":"54","author":"Maguire JJ","year":"2009","unstructured":"Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP. [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension, 2009, 54: 598-604.","journal-title":"Hypertension"},{"key":"null","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","volume":"146","author":"Lee DK","year":"2005","unstructured":"Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O'Dowd BF. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology, 2005, 146: 231-236.","journal-title":"Endocrinology"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/11DCB3798E0F45429BF6D0D96B2771E3","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmx035","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/11DCB3798E0F45429BF6D0D96B2771E3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T13:03:14Z","timestamp":1719147794000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmx035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":88,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmx035","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}